+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Digital Therapeutics Market Report and Forecast 2024-2032

  • PDF Icon


  • 180 Pages
  • February 2024
  • Region: Global
  • Expert Market Research
  • ID: 5797907

Global Digital Therapeutics Market Outlook

The global digital therapeutics market size was valued at USD 4.5 billion in 2023, driven by increase prevalence of diseases like diabetes, cardiovascular diseases, and mental health disorders across the globe. The market size is anticipated to grow at a CAGR of 31.6% during the forecast period of 2024-2032 to achieve a value of USD 53.2 billion by 2032.

Digital Therapeutics: Introduction

Digital therapeutics are evidence-based therapeutic interventions driven by high-quality software programs to prevent, manage, or treat medical disorders and diseases. They are grounded in clinical evidence and often utilize behavioral and lifestyle changes to bolster patient care. Digital therapeutics are accessible, scalable, and can be personalized, offering a revolutionary approach to supplement traditional medical treatments, enhance patient engagement, and improve healthcare outcomes, marking a significant shift in the landscape of modern healthcare solutions.

Key Trends in the Global Digital Therapeutics Market

Digital therapeutics are increasingly being used to manage chronic conditions like diabetes, cardiovascular diseases, and mental health disorders. Their ability to offer personalized care and continuous monitoring is enhancing patient engagement and treatment outcomes.

There's a growing trend of integrating digital therapeutics with traditional healthcare systems. This integration facilitates data-driven decisions, improves patient monitoring, and ensures a more cohesive approach to patient care.

Technological advancements, such as AI, machine learning, and big data analytics, are being leveraged to enhance the capabilities of digital therapeutics. These technologies enable the development of more sophisticated, personalized, and adaptive digital interventions.

Digital therapeutics are receiving increasing support from regulatory bodies, with clear guidelines and pathways for approval. This regulatory support, coupled with clinical validation, is boosting the credibility and adoption of digital therapeutics.

Strategic partnerships between digital therapeutics companies, pharmaceutical firms, and healthcare providers are on the rise. These collaborations aim to accelerate product development, expand market reach, and integrate digital therapeutics into comprehensive treatment plans.

There's a notable surge in the development and adoption of digital therapeutics for mental health conditions. Digital interventions for conditions like depression, anxiety, and stress management are gaining traction, reflecting a broader emphasis on mental wellbeing.

Digital therapeutics are increasingly focusing on patient-centric care models. This involves personalized treatment plans, patient empowerment, and engagement tools, aligning treatment approaches with individual patient needs and preferences.

Global Digital Therapeutics Market Segmentation

Market Breakup by Application

  • Preventive
  • Prediabetes
  • Obesity
  • Others
  • Treatment
  • Diabetes
  • Respiratory Care
  • Mental Health
  • Cardiovascular
  • Others
Market by Breakup by Component
  • Software
  • Device

Market Breakup by End-user

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

Market Breakup by Sales Channel

  • B2B
  • B2C

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Digital Therapeutics Market Overview

North America dominates the digital therapeutics market, driven by a large population suffering from chronic illnesses, advanced healthcare infrastructure, significant technological advancements, and a supportive regulatory environment. The United States, in particular, is at the forefront of adopting and developing digital therapeutic solutions.Europe represents a significant market for digital therapeutics, backed by strong healthcare systems, substantial investment in healthcare IT, and favorable regulatory frameworks. Countries like Germany, the United Kingdom, and France are leading in terms of adoption and innovation in digital therapeutics.

Asia-Pacific is the fastest-growing market for digital therapeutics, propelled by increasing healthcare expenditure, rising prevalence of chronic diseases, and improving healthcare infrastructure. Countries like China and Japan are making significant investments in healthcare IT and are rapidly adopting digital therapeutic solutions.

Latin America and Middle East & Africa regions are emerging markets with growing potential for digital therapeutics. Factors such as increasing healthcare awareness, growing investment in healthcare infrastructure, and rising prevalence of chronic diseases are driving the adoption of digital therapeutic solutions in these regions.

Global Digital Therapeutics Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Omada Health, Inc.
  • Welldoc, Inc.
  • 2Morrow, Inc
  • Livongo Health, Inc. (Teladoc Health, Inc.)
  • Propeller Health (ResMed)
  • Fitbit LLC
  • Mango Health
  • Canary Health
  • Noom, Inc.
  • Pear Therapeutics, Inc.
  • Akill Interactive Labs, Inc.
  • JOGO Health
  • CureApp, Inc.
  • Brain+ A/S

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Digital Therapeutics Market Overview
3.1 Global Digital Therapeutics Market Historical Value (2017-2023)
3.2 Global Digital Therapeutics Market Forecast Value (2024-2032)
4 Global Digital Therapeutics Market Landscape
4.1 Global Digital Therapeutics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Digital Therapeutics Product Landscape
4.2.1 Analysis by Application
4.2.1 Analysis by Component
4.2.2 Analysis by End-user
4.2.3 Analysis by Sales Channel
5 Global Digital Therapeutics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Digital Therapeutics Market Segmentation
6.1 Global Digital Therapeutics Market by Application
6.1.1 Market Overview Preventive Prediabetes Obesity Others Treatment Diabetes Respiratory Care Mental Health Cardiovascular Others
6.2 Global Digital Therapeutics Market by Component
6.2.1 Market Overview
6.2.2 Software
6.2.3 Device
6.3 Global Digital Therapeutics Market by End-user
6.3.1 Market Overview
6.3.2 Patients
6.3.3 Providers
6.3.4 Payers
6.3.5 Employers
6.3.6 Others
6.4 Global Digital Therapeutics Market by Sales Channel
6.4.1 Market Overview
6.4.2 B2B
6.4.3 B2C
6.5 Global Digital Therapeutics Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Digital Therapeutics Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Digital Therapeutics Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Digital Therapeutics Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Others
10 Latin America Digital Therapeutics Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Digital Therapeutics Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by Year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Omada Health, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Welldoc, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 2Morrow, Inc
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Livongo Health, Inc. (Teladoc Health, Inc.)
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Propeller Health (ResMed)
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Fitbit LLC
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Mango Health
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Canary Health
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Noom, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Pear Therapeutics, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Akill Interactive Labs, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 JOGO Health
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 GAIA AG
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 CureApp, Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 Brain+ A/S
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Digital Therapeutics Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Omada Health Inc.
  • Welldoc Inc.
  • 2Morrow Inc
  • Livongo Health Inc. (Teladoc Health Inc.)
  • Propeller Health (ResMed)
  • Fitbit LLC
  • Mango Health
  • Canary Health
  • Noom Inc.
  • Pear Therapeutics Inc.
  • Akill Interactive Labs Inc.
  • JOGO Health
  • CureApp Inc.
  • Brain+ A/S



Table Information